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Antigen Receptor b Chain Variable Region Usage by CD4F and
CD8F T Cells in Psoriasis
To the Editor:
Study of T cell receptor (TCR) expression by lymphocytes in psoriatic
lesions may provide evidence for the occurrence of specific cellular
immune events and indicate the possibility of selective, TCR directed
immunotherapy; however, results to date have not been consistent.
Three groups have analyzed biopsies and peripheral blood either by
labeling with panels of monoclonal antibodies directed against TCR
β chain variable (V) region families, or by polymerase chain reaction
based molecular techniques employing multiple BV family specific
primers. These groups have reported highly skewed lesional TCR
expression, particularly involving BV2 and BV6 families (Lewis et al,
1993; Leung et al, 1995; Menssen et al, 1995). The findings were
interpreted as compatible either with the local effects of superantigen
(Lewis et al, 1993; Leung et al, 1995) or with conventional antigen
(Menssen et al, 1995). A further study found no evidence for increased
expression of selected BV species in psoriasis lesions (Boehncke et al,
1995). Recently, we have developed a highly reproducible anchored
polymerase chain reaction method in which all TCR B chain species
are amplified with the same primer pair, and products quantitated by
dot blot hybridization with BV family specific oligonucleotide probes
(Vekony et al, 1997). Our results suggested that selective accumulation
of T cells expressing certain BV species may occur in early lesions of
psoriasis vulgaris, but that the BV species varied between samples and
that skewing was modest. Furthermore, no BV skewing was seen in a
third of the biopsies analyzed (Vekony et al, 1997). Our results were
supported by an additional recent study employing polymerase chain
reaction and multiple validated BV family specific primers (Moss et al,
1997). In the latter study, preliminary work with several sets of
published BV family specific primer panels showed the different primers
to have an uneven ability to amplify the same BV cDNA. This finding
suggests that the variable results reported to date may arise at least in
part from methodologic differences, in addition to immunogenetic
differences between patients and the state of the psoriasis lesions at the
time of biopsy.
A further study has suggested markedly increased expression of BV3
and/or BV13.1 families by lesional CD81 T cells in psoriasis, indicative
of clonal expansion of this subset, but found no evidence for clonality
amongst CD41 cells (Chang et al, 1994). In this study, keratotome
slices of lesional skin were enzymatically dissociated and fractionated
by fluorescence-activated cell sorting prior to analysis of T cell subset
extracts by polymerase chain reaction with multiple BV family specific
primers. These findings point to a role for CD81 T cells in the
pathogenesis of psoriasis. The findings are supported by the evidence
that CD81 cells are the predominant T cell subset in lesional epidermis
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(Baker et al, 1984; Jones et al, 1994), by the reported deterioration of
psoriasis in patients with progressive AIDS (Duvic et al, 1987), and, as
antigens are presented to CD81 T cells by major histocompatibility
complex class I molecules, by the major histocompatibility complex
class I association of psoriasis in epidemiologic (Elder et al, 1994) and
genetic (Trembath et al, 1997) studies. We have therefore re-investigated
the TCR BV expression by CD41 and CD81 T cells in psoriatic
lesions, by using our anchored polymerase chain reaction method,
particularly in view of the variable results that have been obtained in
recent studies, and the fact that there are no other reports of the
analysis of BV expression by T cell subsets in psoriasis.
Following ethical committee approval, six volunteers (age 32–59 y;
five male, one female; PASI scores 10–20) with chronic plaque psoriasis
that had not received treatment apart from bland emollients for at least
a week, each provided venous blood samples and two punch biopsies (4–
5 mm diameter) under local anesthesia with lignocaine and adrenaline.
Biopsies were taken either from the edge and center of the same lesion
or from adjacent small plaque lesions, rinsed free of blood in cold
phosphate buffered saline, placed in ice-cold RPMI-1640 medium
containing 1% fetal calf serum, and subjected to further processing
within 60–90 min. Subcutaneous fat and deep dermis were trimmed
away and the remaining sample cut into small pieces. These were
incubated for 30 min at 37°C in RPMI-1640 medium containing 1%
fetal calf serum, 0.5 mM CaCl2, and 0.3% collagenase (type 1A, Sigma,
Poole, U.K.). The pieces were then mechanically disaggregated in
a Medimachine (Dako, High Wycombe, U.K.) according to the
manufacturer’s instructions and the cell suspensions separated into
CD41 and CD81 fractions with anti-CD8 conjugated immuno-
magnetic beads (Dynabeads M-450; Dynal, Wirral, U.K.). Briefly, cells
were incubated with a large excess of the beads with continuous
rocking for 60 min at 4°C. CD81 cells were recovered by magnet
and washed, and the unbound cells taken as the CD41 fraction.
Peripheral blood mononuclear cells (PBMC) were obtained from
venous blood by density gradient centrifugation, and 107 cells separated
with a 3-fold excess of immunomagnetic beads. RNA was isolated
from CD41 and CD81 fractions (the latter without detachment from
beads), contaminating DNA removed by incubation with RNase-free
DNase, and residual RNA quantitated spectrophotometrically (Vekony
et al, 1997). TCR β-chain cDNA was synthesized from 20 ng (CD81
fractions) or 100 ng (CD41 fractions) total RNA, tailed with poly (A),
and amplified by two-step, seminested, anchored polymerase chain
reaction. Following clean-up and spectrophotometric quantitation,
second round polymerase chain reaction products were separated into
25,100 ng aliquots, and subjected to dot blot hybridization with 25
[32P]-labeled, BV family specific oligonucleotide probes, bound probes
being quantitated by PhosphoImager (Vekony et al, 1997). The amount
of each bound probe was expressed as a percentage of the sum of all
bound probes for each sample.
Sufficient RNA for complete assay of CD41 and CD81 fractions
from both skin biopsies and PBMC was obtained in four of the six
patients. If significant lesional expansion of a specific BV family is
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Table I. BV expression by CD4F and CD8F cells in PBMC and lesional biopsies
CD4 CD4 CD4 CD8 CD8 CD8
PBMC biopsy A biopsy B PBMC biopsy A biopsy B
Patient 1 BV5Ba 2% 7.5% 4.2%
BV18 0.5% 5% 4.9%
Patient 3b BV13 6.1% 11.6% 14.7%
Patient 4 BV6 7.5% 15.8% 12.4%
BV7 2.3% 4.5% 6.2%
BV9 1.6% 6.1% 4.5%
aTwo probes, designated 5A and 5B, were required to allow detection of all BV5 family members (Vekony et al, 1997).
bThere was no significantly skewed BV expression by either CD41 or CD81 cells in the two lesional biopsies of patient 2. In patient 3, there was no skewing of BV expression by
lesional CD41 cells.
defined as an approximately 2-fold or greater mean increase in lesional
versus PBMC BV expression, with mean lesional expression of the
specific BV family representing at least 5% of the total, then significant
expansion amongst CD81 cells was seen in three of the four patients
and amongst CD41 cells in two of four patients. The BV families
involved and the percentage expression in PBMC and both lesional
biopsies are shown in Table I. Among lesional CD81 cells, increased
expression of BV6 was seen in one patient, of BV13 in another, and
of BV18 in a third. Among lesional CD41 cells, an increase of BV5
was seen in one patient and of BV7 and BV9 in another. In contrast
with the previous report (Chang et al, 1994), we found no evidence
for lesional expansion of CD81 T cells expressing the BV3 family, and
increased BV13 was seen in only one of four patients.
In our work, full thickness punch biopsies of skin, trimmed of
subcutaneous fat and deeper dermis, were subjected to analysis;
however, we do not believe that this fact explains the differences
between the present and previously reported work, in which ‘‘epi-
dermal’’ samples were obtained by keratotome (Chang et al, 1994). As
previously argued (Vekony et al, 1997), keratotome biopsies of psoriatic
lesions are likely to include superficial dermis, which contains the
major portion of lesional T cell infiltrates. More precise molecular
analysis of the clonality of intraepidermal CD81 T cells in psoriatic
lesions requires recovery of epidermis uncontaminated with dermis, a
procedure fraught with difficulty in view of the highly irregular
epidermal hyperplasia and suprapapillary epidermal thinning character-
istic of psoriatic lesions (Camp, 1992).
This work is compatible with the possibility that clonal expansion
of CD81 T cells occurs in some psoriatic skin lesions; however, our
findings suggest that skewing of BV expression by lesional CD81 cells
versus PBMC is relatively modest and more variable than previously
reported (Chang et al, 1994), and that any TCR directed therapy for
psoriasis should be customised for each patient.
Richard D.R. Camp, Moira A. Vekony
Division of Dermatology, University of Leicester, Leicester, U.K.
Investigation of Water Sorption on Porcine Stratum Corneum
by Very Small Angle Neutron Scattering
To the Editor:
Stratum corneum (SC), the outermost layer of the epidermis, plays an
important role in the diffusion of water and drugs through the skin.
The SC consists of layers of dead keratinized cells, the corneocytes,
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surrounded by a lipid matrix. In the intercellular region, lipids are
arranged in a lamellar phase consisting of alternative layers of water
and lipid bilayers, whereas in the protein domains the corneocytes are
enveloped in a lipid continuum. An important property of SC is that
increased hydration leads to enhanced drug penetration (Roberts and
Walker, 1993); however, the route that water follows through SC
(intercellular or transcellular) still remains questionable (Barry, 1991).
To this end, the use of new and combined techniques in SC
investigation is a matter of interest.
Very small angle neutron scattering is a modern nondestructive
